Antiarrhythmic therapy in atrial fibrillation

Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.

Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., Garrigue, S., Mouroux, A. L., Métayer, P. L., & Clémenty, J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809033391003 · Cited by 8,040 · see citing works

Cardiac excitation–contraction coupling

Bers, D., & Despa, S. (2002) · Nature · doi:10.1038/415198a · Cited by 4,927 · see citing works

A comparison of rate control and rhythm control in patients with atrial fibrillation

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405 · see citing works

Atrial Fibrillation Begets Atrial Fibrillation

WIJFFELS, M. C. E. F., Kirchhof, C. J. H. J., Dorland, R., & Allessie, M. A. (1995) · Circulation · doi:10.1161/01.cir.92.7.1954 · Cited by 3,500 · see citing works

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo

Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,244 · see citing works

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.

Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033 · see citing works

Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study

Heeringa, J., van der Kuip, D. A. M., Hofman, A., Kors, J. A., van Herpen, G., Stricker, B. H. C., Stijnen, T., Lip, G. Y. H., & Witteman, J. C. M. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi825 · Cited by 1,939 · see citing works

hERG potassium channels and cardiac arrhythmia

Sanguinetti, M. C., & Tristani‐Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,582 · see citing works

Promotion of Atrial Fibrillation by Heart Failure in Dogs

Li, D., Fareh, S., Leung, T. K., & Nattel, S. (1999) · Circulation · doi:10.1161/01.cir.100.1.87 · Cited by 1,343 · see citing works

Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications

Nattel, S., Burstein, B., & Dobrev, D. (2008) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.107.754564 · Cited by 1,124 · see citing works

Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle.

Allessie, M. A., BONKE, F. I. M., & Schopman, F. J. G. (1977) · Circulation Research · doi:10.1161/01.res.41.1.9 · Cited by 1,074 · see citing works

Chronic Rapid Atrial Pacing

Morillo, C. A., Klein, G. J., Jones, D. L., & Guiraudon, C. M. (1995) · Circulation · doi:10.1161/01.cir.91.5.1588 · Cited by 1,046 · see citing works

Lenient versus strict rate control in patients with atrial fibrillation

Van Gelder, I. C., Groenveld, H. F., Crijns, H. J. G. M., Tuininga, Y. S., Tijssen, J. G. P., Alings, A. M., Hillege, H. L., Bergsma-Kadijk, J. A., Cornel, J. H., Kamp, O., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001337 · Cited by 1,033 · see citing works

Beneficial Cardiovascular Pleiotropic Effects of Statins

Davignon, J. (2004) · Circulation · doi:10.1161/01.cir.0000131517.20177.5a · Cited by 955 · see citing works

Electrophysiological End Point for Catheter Ablation of Atrial Fibrillation Initiated From Multiple Pulmonary Venous Foci

Haı̈ssaguerre, M., Jaı̈s, P., Shah, D. C., Garrigue, S., Takahashi, A., Lavergne, T., Hocini, M., Peng, J. T., Roudaut, R. P., & Clémenty, J. (2000) · Circulation · doi:10.1161/01.cir.101.12.1409 · Cited by 921 · see citing works

Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation

Nattel, S., Maguy, A., Bouter, S. L., & Yeh, Y. (2007) · Physiological Reviews · doi:10.1152/physrev.00014.2006 · Cited by 857 · see citing works

Potassium leak channels and the KCNK family of two-p-domain subunits

Goldstein, S. A. N., Böckenhauer, D., O'Kelly, I., & Zilberberg, N. (2001) · Nature reviews. Neuroscience · doi:10.1038/35058574 · Cited by 721 · see citing works

Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties

Antzelevitch, C. N., Belardinelli, L., Zygmunt, A. C., Burashnikov, A., Diego, J. M. D., Fish, J. M., Cordeiro, J. M., & Thomas, G. (2004) · Circulation · doi:10.1161/01.cir.0000139333.83620.5d · Cited by 674 · see citing works

Structural Changes of Atrial Myocardium due to Sustained Atrial Fibrillation in the Goat

Ausma, J., WIJFFELS, M. C. E. F., Thoné, F., Wouters, L., Allessie, M. A., & Borgers, M. J. (1997) · Circulation · doi:10.1161/01.cir.96.9.3157 · Cited by 669 · see citing works

ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation–executive summary

Authors Task Force Members, Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl176 · Cited by 645 · see citing works

Structural Changes of Atrial Myocardium due to Sustained Atrial Fibrillation in the Goat

JannieAusma, MauritsWijffels, FredThoné, LucWouters, MauritsAllessie, & MarcelBorgers (1997) · Circulation · Cited by 618 · see citing works

Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring

Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.23.2851 · Cited by 600 · see citing works

The effects of connexin phosphorylation on gap junctional communication

Lampe, P. D., & Lau, A. F. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00264-4 · Cited by 591 · see citing works

Ionic mechanisms of electrical remodeling in human atrial fibrillation

BOSCH, R. F. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00178-9 · Cited by 566 · see citing works

Remodelling of gap junctions and connexin expression in diseased myocardium

Severs, N. J., Bruce, A. F., Dupont, E., & ROTHERY, S. M. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn133 · Cited by 563 · see citing works

Outward K + Current Densities and Kv1.5 Expression Are Reduced in Chronic Human Atrial Fibrillation

Wagoner, D. R. V., Pond, A. L., McCarthy, P. M., Trimmer, J. S., & Nerbonne, J. M. (1997) · Circulation Research · doi:10.1161/01.res.80.6.772 · Cited by 556 · see citing works

The effect of amiodarone, a new anti‐anginal drug, on cardiac muscle

Singh, B. N., & Williams, E. M. V. (1970) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1970.tb09891.x · Cited by 554 · see citing works

Antiarrhythmic Agents: The Modulated Receptor Mechanism of Action of Sodium and Calcium Channel-Blocking Drugs

Hondeghem, L. M., & Katzung, B. G. (1984) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.24.040184.002131 · Cited by 554 · see citing works

The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.

(1991) · Circulation · doi:10.1161/01.cir.84.4.1831 · Cited by 545 · see citing works

Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation

Carnes, C. A., Chung, M. K., Nakayama, T., Nakayama, H., Baliga, R. S., Piao, S., KANDERIAN, A. S., Pavia, S., Hamlin, R. L., McCarthy, P. M., et al. (2001) · Circulation Research · doi:10.1161/hh1801.097644 · Cited by 524 · see citing works

Structural correlate of atrial fibrillation in human patients

Sawa Kostin, D. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00273-0 · Cited by 512 · see citing works

Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation

Olson, T. M., Alekseev, A. E., Liu, X., Park, S., Zingman, L. V., Bienengraeber, M., Sattiraju, S., Ballew, J. D., Jahangir, A., & Terzic, A. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl143 · Cited by 491 · see citing works

Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation

Stambler, B. S., Wood, M. A., Ellenbogen, K. A., Perry, K. T., Wakefield, L. K., & VanderLugt, J. T. (1996) · Circulation · doi:10.1161/01.cir.94.7.1613 · Cited by 485 · see citing works

Common variants in KCNN3 are associated with lone atrial fibrillation

Ellinor, P. T., Lunetta, K. L., Glazer, N. L., Pfeufer, A., Alonso, A., Chung, M. K., Sinner, M. F., de Bakker, P. I. W., Mueller, M., Lubitz, S. A., et al. (2010) · Nature Genetics · doi:10.1038/ng.537 · Cited by 485 · see citing works

Outpatient treatment of recent-onset atrial fibrillation with the “Pill-in-the-Pocket” approach

Alboni, P., Botto, G. L., Baldi, N., Luzi, M., Russo, V., Gianfranchi, L., Marchi, P., Calzolari, M., Solano, A., Baroffio, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041233 · Cited by 479 · see citing works

Prevention of Atrial Fibrillation

Benjamin, E. J., Chen, P., Bild, D. E., Mascette, A. M., Albert, C. M., Alonso, Á., Calkins, H. G., Connolly, S. J., Curtis, A. B., Darbar, D., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.825380 · Cited by 471 · see citing works

A dynamic model of the cardiac ventricular action potential. II. Afterdepolarizations, triggered activity, and potentiation.

Luo, C. H., & Rudy, Y. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1097 · Cited by 467 · see citing works

Pharmacology of cardiac potassium channels

Tamargo, J. L. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.12.026 · Cited by 466 · see citing works

Calcium-Activated Potassium Channels and the Regulation of Vascular Tone

Ledoux, J., Werner, M. E., Brayden, J. E., & Nelson, M. T. (2006) · Physiology · doi:10.1152/physiol.00040.2005 · Cited by 464 · see citing works

The G Protein–Gated Potassium Current I K,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation

Dobrev, D., Friedrich, A., Voigt, N., Jost, N., Wettwer, E., Christ, T., Knaut, M., & Ravens, U. (2005) · Circulation · doi:10.1161/circulationaha.105.575332 · Cited by 463 · see citing works

Molecular basis of functional voltage‐gated K + channel diversity in the mammalian myocardium

Nerbonne, J. M. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.t01-1-00285.x · Cited by 453 · see citing works

Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome

Scirica, B. M., Morrow, D. A., Hod, H., Murphy, S. A., Belardinelli, L., Hedgepeth, C. M., Molhoek, P. G., Verheugt, F. W. A., Gersh, B. J., McCabe, C. H., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.724880 · Cited by 444 · see citing works

Valsartan for prevention of recurrent atrial fibrillation

(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805710 · Cited by 441 · see citing works

Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts.

Peters, N. S., Green, C. R., Poole-Wilson, P. A., & Severs, N. J. (1993) · Circulation · doi:10.1161/01.cir.88.3.864 · Cited by 439 · see citing works

Efficacy and Safety of Oral Dofetilide in Converting to and Maintaining Sinus Rhythm in Patients With Chronic Atrial Fibrillation or Atrial Flutter: The Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) Study

Singh, S., Zoble, R. G., Yellen, L., Brodsky, M. A., Feld, G. K., Berk, M., & Billing, C. B. (2000) · Circulation · doi:10.1161/01.cir.102.19.2385 · Cited by 433 · see citing works

Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial Fibrillation

Burashnikov, A., Diego, J. M. D., Zygmunt, A. C., Belardinelli, L., & Antzelevitch, C. N. (2007) · Circulation · doi:10.1161/circulationaha.107.704890 · Cited by 399 · see citing works

Regulation of cardiac ion channels by catecholamines, acetylcholine and second messenger systems

Hartzell, H. C. (1988) · Progress in Biophysics and Molecular Biology · doi:10.1016/0079-6107(88)90014-4 · Cited by 399 · see citing works

Ventricular Fibrillation: Mechanisms of Initiation and Maintenance

Jalife, J. (2000) · Annual Review of Physiology · doi:10.1146/annurev.physiol.62.1.25 · Cited by 380 · see citing works

Atrial Fibrillation Is Associated With Increased Spontaneous Calcium Release From the Sarcoplasmic Reticulum in Human Atrial Myocytes

Hove-Madsen, L., Llach, A., Bayés-Genís, A., Roura, S., Font, E. R., Arís, A., & Cinca, J. (2004) · Circulation · doi:10.1161/01.cir.0000141296.59876.87 · Cited by 363 · see citing works

Defective Cardiac Ryanodine Receptor Regulation During Atrial Fibrillation

Vest, J. A., Wehrens, X. H. T., Reiken, S. R., Lehnart, S. E., Dobrev, D., Chandra, P., Danilo, P., Ravens, U., Rosen, M. R., & Marks, A. R. (2005) · Circulation · doi:10.1161/01.cir.0000162461.67140.4c · Cited by 352 · see citing works

The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation

Korantzopoulos, P. G., Kolettis, T. M., Galaris, D., & Goudevenos, J. A. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.04.026 · Cited by 342 · see citing works

Cellular electropharmacology of amiodarone

Kodama, I. (1997) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00114-4 · Cited by 342 · see citing works

Mechanisms of use-dependent block of sodium channels in excitable membranes by local anesthetics

Starmer, C. F., Grant, A. O., & Strauss, H. C. (1984) · Biophysical Journal · doi:10.1016/s0006-3495(84)83994-6 · Cited by 339 · see citing works

Valsartan for Prevention of Recurrent Atrial Fibrillation

Modena, M. G. (2009) · New England Journal of Medicine · doi:10.1056/nejmx090019 · Cited by 328 · see citing works

Voltage- and time-dependent block of the delayed K+ current in cardiac myocytes by dofetilide.

Carmeliet, E. E. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10827-6 · Cited by 322 · see citing works

Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation

Roy, D., Pratt, C. M., Torp-Pedersen, C. T., Wyse, D. G., Toft, E. S., Juul‐Möller, S., Nielsen, T., Rasmussen, S., Stiell, I. G., Coutu, B., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.723866 · Cited by 321 · see citing works

Molecular Basis of Downregulation of G-Protein–Coupled Inward Rectifying K+Current (IK,ACh) in Chronic Human Atrial Fibrillation

Dobrev, D., Graf, E., Wettwer, E., Himmel, H. M., Hála, O., Doerfel, C., Christ, T., Schüler, S., & Ravens, U. (2001) · Circulation · doi:10.1161/hc4601.099466 · Cited by 320 · see citing works

Tarantula peptide inhibits atrial fibrillation

Bode, F., Sachs, F., & Franz, M. R. (2001) · Nature · doi:10.1038/35051165 · Cited by 306 · see citing works

A novel antagonist, No. 7943, of the Na+/Ca2+ exchange current in guinea‐pig cardiac ventricular cells

Watano, T., Kimura, J., Morita, T., & Nakanishi, H. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15708.x · Cited by 303 · see citing works

Role of IKur in Controlling Action Potential Shape and Contractility in the Human Atrium: Influence of Chronic Atrial Fibrillation

Wettwer, E., Hála, O., Christ, T., Heubach, J., Dobrev, D., Knaut, M., Varró, A., & Ravens, U. (2004) · Circulation · doi:10.1161/01.cir.0000145155.60288.71 · Cited by 295 · see citing works

Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria

Polontchouk, L., Haefliger, J., Ebelt, B., Schaefer, T., Stuhlmann, D., Mehlhorn, U., Kuhn‐Régnier, F., de Vivie, E. R., & Dhein, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01443-7 · Cited by 292 · see citing works

L-Type Ca 2+ Current Downregulation in Chronic Human Atrial Fibrillation Is Associated With Increased Activity of Protein Phosphatases

Christ, T., Boknı́k, P., Wöhrl, S., Wettwer, E., Graf, E., BOSCH, R. F., Knaut, M., Schmitz, W. L., Ravens, U., & Dobrev, D. (2004) · Circulation · doi:10.1161/01.cir.0000145659.80212.6a · Cited by 291 · see citing works

Molecular Identification and Functional Roles of a Ca2+-activated K+ Channel in Human and Mouse Hearts

Xu, Y., Tuteja, D., Zhang, Z., Xu, D., Zhang, Y., Rodriguez, J., Nie, L., Tuxson, H. R., Young, J. N., Glatter, K. A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307508200 · Cited by 284 · see citing works

Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Cardioversion of Atrial Fibrillation

Lafuente‐Lafuente, C., Mouly, S. J., Longás-Tejero, M. A., Mahé, I., & Bergmann, J. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.7.719 · Cited by 283 · see citing works

Molecular Determinants of Altered Ca 2+ Handling in Human Chronic Atrial Fibrillation

El‐Armouche, A., Boknı́k, P., Thomas Eschenhagen, A., Carrier, L., Knaut, M., Ravens, U., & Dobrev, D. (2006) · Circulation · doi:10.1161/circulationaha.106.636845 · Cited by 274 · see citing works

Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation

Kühlkamp, V., Schirdewan, A., Stangl, K., Homberg, M., Ploch, M., & Beck, O. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00693-8 · Cited by 256 · see citing works

Tachycardia-Induced Changes in Na+Current in a Chronic Dog Model of Atrial Fibrillation

Gaspo, R., BOSCH, R. F., Bou‐Abboud, E., & Nattel, S. (1997) · Circulation Research · doi:10.1161/01.res.81.6.1045 · Cited by 256 · see citing works

Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat

van der Velden, H. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00026-2 · Cited by 250 · see citing works

Human Atrial Ion Channel and Transporter Subunit Gene-Expression Remodeling Associated With Valvular Heart Disease and Atrial Fibrillation

Gaborit, N., Steenman, M., Lamirault, G., Meur, N. L., Bouter, S. L., Lande, G., Leger, J. J., Charpentier, F., Christ, T., Dobrev, D., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.506857 · Cited by 249 · see citing works

Ionic Determinants of Functional Reentry in a 2-D Model of Human Atrial Cells During Simulated Chronic Atrial Fibrillation

Pandit, S. V., Berenfeld, O., ANUMONWO, J. M. B., Zaritski, R. M., Kneller, J., Nattel, S., & Jalife, J. (2005) · Biophysical Journal · doi:10.1529/biophysj.105.060459 · Cited by 247 · see citing works

Differences between outward currents of human atrial and subepicardial ventricular myocytes.

Amos, G. J., Wettwer, E., Metzger, F., Li, Q., Himmel, H. M., & Ravens, U. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021194 · Cited by 241 · see citing works

Reverse Structural and Gap-Junctional Remodeling After Prolonged Atrial Fibrillation in the Goat

Ausma, J., van der Velden, H. M. W., Lenders, M. ‐., van Ankeren, E. P., Jongsma, H. J., Ramaekers, F. C. S., Borgers, M. J., & Allessie, M. A. (2003) · Circulation · doi:10.1161/01.cir.0000062689.04037.3f · Cited by 241 · see citing works

Evaluation of the role of IKAChin atrial fibrillation using a mouse knockout model

Kovoor, P., Wickman, K. D., Maguire, C. T., Pu, W. T., Gehrmann, J., Berul, C. I., & Clapham, D. E. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01304-3 · Cited by 239 · see citing works

Classification of antidysrhythmic drugs

E.M.Vaughan Williams, D. M. (1975) · Pharmacology & Therapeutics Part B General and Systematic Pharmacology · doi:10.1016/0306-039x(75)90019-7 · Cited by 217 · see citing works

The effect of altered thyroid state on atrial intracellular potentials

FREEDBERG, A. S., Papp, J. G., & Williams, E. M. V. (1970) · The Journal of Physiology · doi:10.1113/jphysiol.1970.sp009066 · Cited by 214 · see citing works

Management of Atrial Fibrillation: Review of the Evidence for the Role of Pharmacologic Therapy, Electrical Cardioversion, and Echocardiography

McNamara, R. L., Tamariz, L. J., Segal, J. B., & Bass, E. B. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-12-200312160-00012 · Cited by 211 · see citing works

Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+channels

Brundel, B. J. J. M., Gelder, I. C. V., Henning, R. H., Tuinenburg, A. E., Wietses, M., Grandjean, J. G., Wilde, A. A. M., van Gilst, W. H., & Crijns, H. J. G. M. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01195-5 · Cited by 211 · see citing works

A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland

Murphy, N., Simpson, C., Jhund, P., Stewart, S., Kirkpatrick, M., Chalmers, J., Macintyre, K., & McMurray, J. (2007) · Heart · doi:10.1136/hrt.2006.107573 · Cited by 209 · see citing works

Frequency-Dependent Breakdown of Wave Propagation Into Fibrillatory Conduction Across the Pectinate Muscle Network in the Isolated Sheep Right Atrium

Berenfeld, O., Зайцев, А. В., Mironov, S. F., Pertsov, A. M., & Jalife, J. (2002) · Circulation Research · doi:10.1161/01.res.0000022854.95998.5c · Cited by 208 · see citing works

Supraventricular Tachycardia

Delacrétaz, E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp051145 · Cited by 202 · see citing works

Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference ‘research perspectives in AF’

Kirchhof, P., Bax, J., Blomstrom-Lundquist, C., Calkins, H., Camm, A. J., Cappato, R., Cosio, F., Crijns, H., Diener, H.-C., Goette, A., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp235 · Cited by 202 · see citing works

Ablation of a Ca2+‐activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation

Li, N., Timofeyev, V., Tuteja, D., Xu, D., Lü, L., Zhang, Q., Zhang, Z., Singapuri, A., Albert, T. R., Rajagopal, A., et al. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2008.167718 · Cited by 202 · see citing works

Superiority of ibutilide (a new class III agent) overdl-sotalol in converting atrial flutter and atrial fibrillation

Vos, M. A., Golitsyn, S. R., Stangl, K., Ruda, M. Y., Van Wijk, L., Harry, J. D., Perry, K. T., Touboul, P., Steinbeck, G., & Wellens, H. J. J. (1998) · Heart · doi:10.1136/hrt.79.6.568 · Cited by 200 · see citing works

The Mechanism of Atrial Antiarrhythmic Action of RSD1235

Fedida, D., ORTH, P. M. R., CHEN, J. Y. C., Lin, S., Plouvier, B., Jung, G., Ezrin, A. M., & Beatch, G. N. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.50028.x · Cited by 195 · see citing works

Ibutilide, a Methanesulfonanilide Antiarrhythmic, Is a Potent Blocker of the Rapidly Activating Delayed Rectifier K + Current (I Kr ) in AT-1 Cells

Yang, T., Snyders, D. J., & Roden, D. M. (1995) · Circulation · doi:10.1161/01.cir.91.6.1799 · Cited by 193 · see citing works

Remodeling of cardiomyocyte ion channels in human atrial fibrillation

Dobrev, D., & Ravens, U. (2003) · Basic Research in Cardiology · doi:10.1007/s00395-003-0409-8 · Cited by 192 · see citing works

Electrophysiological Effects of Dronedarone (SR33589), a Noniodinated Benzofuran Derivative, in the Rabbit Heart

Sun, W., Sarma, J. S. M., & Singh, B. N. (1999) · Circulation · doi:10.1161/01.cir.100.22.2276 · Cited by 189 · see citing works

Oxidative Stress and Inflammation in Atrial Fibrillation: Role in Pathogenesis and Potential as a Therapeutic Target

Wagoner, D. R. V. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31817f9398 · Cited by 188 · see citing works

Kir3-Based Inward Rectifier Potassium Current

Cha, T., Ehrlich, J. R., Chartier, D., Qi, X., Xiao, L., & Nattel, S. (2006) · Circulation · doi:10.1161/circulationaha.105.561738 · Cited by 183 · see citing works

Cardiac fibrillation: From ion channels to rotors in the human heart

Vaquero, L. M., Calvo, D., & Jalife, J. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.02.034 · Cited by 181 · see citing works

Cardiac sodium channel mutation in atrial fibrillation

Ellinor, P. T., Nam, E. G., Shea, M. A., Milan, D. J., Ruskin, J. N., & MacRae, C. A. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.09.015 · Cited by 180 · see citing works

Rate-Dependent Class III Antiarrhythmic Action, Negative Chronotropy, and Positive Inotropy of a Novel Ik Blocking Drug, UK-68,798

Tande, P. M., Bjørnstad, H., Yang, T., & Refsum, H. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199009000-00008 · Cited by 177 · see citing works

“Early” Class III Drugs for the Treatment of Atrial Fibrillation

Blaauw, Y., Gögelein, H., Tieleman, R. G., van Hunnik, A., Schotten, U., & Allessie, M. A. (2004) · Circulation · doi:10.1161/01.cir.0000143050.22291.2e · Cited by 173 · see citing works

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials

Naccarelli, G. V., Wolbrette, D. L., Khan, M. R., Bhatta, L., Hynes, J. K., Samii, S. M., & Luck, J. C. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03375-1 · Cited by 172 · see citing works

Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes.

Wang, Z., Fermini, B., & Nattel, S. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24304-x · Cited by 166 · see citing works

Current concepts in the pathogenesis of atrial fibrillation

Kourliouros, A., Savelieva, I., Kiotsekoglou, A., Jahangiri, M., & Camm, A. J. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.10.009 · Cited by 166 · see citing works

Characterization of a hyperpolarization‐activated time‐dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium

Ehrlich, J. R., Cha, T., Zhang, L., Chartier, D., Villeneuve, L. R., Hébert, T. E., & Nattel, S. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.061119 · Cited by 161 · see citing works

Functional characterization of a Ca 2+ ‐activated non‐selective cation channel in human atrial cardiomyocytes

Guinamard, R., Chatelier, A., Demion, M., Potreau, D., Patri, S., Rahmati, M., & Bois, P. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.063974 · Cited by 160 · see citing works

Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2 channels to membrane sites

Özgen, N., Dun, W., Sosunov, E. A., Anyukhovsky, E. P., HIROSE, M., Duffy, H. S., Boyden, P. A., & ROSEN, M. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.008 · Cited by 157 · see citing works

The acid-sensitive potassium channel TASK-1 in rat cardiac muscle

Putzke, C., Wemhöner, K., Sachse, F. B., Rinné, S., Schlichthörl, G., LI, X., Jae, L. T., Eckhardt, I., Wischmeyer, E., & Wulf, H. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.02.025 · Cited by 156 · see citing works

Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells.

Dukes, I. D., Cleemann, L. N., & Morad, M. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12766-3 · Cited by 155 · see citing works

Ibutilide

Murray, K. T. (1998) · Circulation · doi:10.1161/01.cir.97.5.493 · Cited by 155 · see citing works

Of circles and spirals: Bridging the gap between the leading circle and spiral wave concepts of cardiac reentry

Comtois, P., Kneller, J., & Nattel, S. (2005) · EP Europace · doi:10.1016/j.eupc.2005.05.011 · Cited by 151 · see citing works

Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells.

Lee, K. S. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10779-9 · Cited by 147 · see citing works

Differential phosphorylation-dependent regulation of constitutively active and muscarinic receptor-activated IK,ACh channels in patients with chronic atrial fibrillation

Voigt, N., Friedrich, A., Bock, M., Wettwer, E., Christ, T., Knaut, M., Strasser, R. H., Ravens, U., & Dobrev, D. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.02.009 · Cited by 142 · see citing works

Dronedarone

Patel, C., Yan, G., & Kowey, P. R. (2009) · Circulation · doi:10.1161/circulationaha.109.858027 · Cited by 141 · see citing works

Role of atrial electrophysiology and autonomic nervous system in patients with supraventricular tachycardia and paroxysmal atrial fibrillation

Chen, Y., Chen, S.-A., TAI, C., Wen, Z.-C., Feng, A.-N., Ding, Y.-A., & Chang, M.-S. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00305-2 · Cited by 140 · see citing works

Do human atrial 5-HT4 receptors mediate arrhythmias?

Kaumann, A. J. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90058-2 · Cited by 139 · see citing works

Knockout Mice for Pharmacological Screening

Reuter, H., Henderson, S. A., Han, T.-Y., Matsuda, T., Baba, A., Ross, R. S., Goldhaber, J. I., & Philipson, K. D. (2002) · Circulation Research · doi:10.1161/01.res.0000027529.37429.38 · Cited by 134 · see citing works

Model-Dependent Effects of the Gap Junction Conduction–Enhancing Antiarrhythmic Peptide Rotigaptide (ZP123) on Experimental Atrial Fibrillation in Dogs

Shiroshita-Takeshita, A., Sakabe, M., Haugan, K., Hennan, J. K., & Nattel, S. (2007) · Circulation · doi:10.1161/circulationaha.106.665547 · Cited by 133 · see citing works

Inflammation Effects on the Electrical Properties of Atrial Tissue and Inducibility of Postoperative Atrial Fibrillation

Tselentakis, E. V., Woodford, E. J., Chandy, J., Gaudette, G. R., & Saltman, A. E. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.03.024 · Cited by 132 · see citing works

Calcium Handling Abnormalities in Atrial Fibrillation as a Target for Innovative Therapeutics

Dobrev, D., & Nattel, S. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318171924d · Cited by 132 · see citing works

Automatie-f�rdernde Dehnungseffekte an Purkinje-F�den, Papillarmuskeln und Vorhoftrabekeln von Rhesus-Affen

KAUFMANN, R. L., & Theophile, U. (1967) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00362710 · Cited by 132 · see citing works

Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation

Sood, S., Chelu, M. G., van Oort, R. J., Skapura, D. G., Santonastasi, M., Dobrev, D., & Wehrens, X. H. T. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.03.030 · Cited by 132 · see citing works

Effects of the Gap Junction Modifier Rotigaptide (ZP123) on Atrial Conduction and Vulnerability to Atrial Fibrillation

Palmero, M. J. G., Everett, T. H., Lee, K. W., Wilson, E., & Olgin, J. E. (2006) · Circulation · doi:10.1161/circulationaha.105.606251 · Cited by 128 · see citing works

Electrophysiologic Characterization of Dronedarone in Guinea Pig Ventricular Cells

Gautier, P., Guillemare, E., Marion, A., Bertrand, J.-P., Tourneur, Y., & Nisato, D. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200302000-00007 · Cited by 127 · see citing works

Pathology‐specific effects of the I Kur / I to / I K,ACh blocker AVE0118 on ion channels in human chronic atrial fibrillation

Christ, T., Wettwer, E., Voigt, N., Hála, O., Radicke, S., Matschke, K., Varró, A., Dobrev, D., & Ravens, U. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.209 · Cited by 121 · see citing works

Effects of SEA0400 and KB-R7943 on Na+/Ca2+ exchange current and L-type Ca2+ current in canine ventricular cardiomyocytes

Birinyi, P., Acsai, K., Bányász, T., Tóth, A. J., Horváth, B., Virág, L., Szentandrássy, N., Magyar, J., Varró, A., Fülöp, F., et al. (2005) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-005-1079-x · Cited by 118 · see citing works

RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents

ORTH, P., HESKETH, J., MAK, C., YANG, Y., Lin, S., Beatch, G. N., Ezrin, A. M., & Fedida, D. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.01.026 · Cited by 117 · see citing works

Mechanical deformation of ventricular myocytes modulates both TRPC6 and Kir2.3 channels

Dyachenko, V., Husse, B., Rueckschloss, U., & Isenberg, G. (2008) · Cell Calcium · doi:10.1016/j.ceca.2008.06.003 · Cited by 117 · see citing works

Polyunsaturated Fatty Acid Modulation of Voltage-Gated Ion Channels

Boland, L. M., & Drzewiecki, M. M. (2008) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-008-9027-2 · Cited by 117 · see citing works

Effects of a Na+/Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity

Wongcharoen, W., Chen, Y., CHEN, Y., CHANG, C., YEH, H., LIN, C., & CHEN, S. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.02.026 · Cited by 116 · see citing works

Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone

Varró, A., Takács, J., Németh, M., Hála, O., Virág, L., Iost, N., Baláti, B., Ágoston, M., Vereckei, A., Pastor, G., et al. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704106 · Cited by 115 · see citing works

Novel, Potent Inhibitors of Human Kv1.5 K+ Channels and Ultrarapidly Activating Delayed Rectifier Potassium Current

Lagrutta, A., Wang, J., Fermini, B., & Salata, J. J. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101162 · Cited by 115 · see citing works

Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+currents and Na+current in human atrial myocytes

Li, G., Sun, H., Zhang, X., Cheng, L., Chiu, S., Tse, H., & Lau, C.-P. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn322 · Cited by 115 · see citing works

The Antiarrhythmic Effect of n-3 Polyunsaturated Fatty Acids: Modulation of Cardiac Ion Channels as a Potential Mechanism

Xiao, Y., Sigg, D. C., & Leaf, A. (2005) · The Journal of Membrane Biology · doi:10.1007/s00232-005-0786-z · Cited by 114 · see citing works

Molecular mechanisms of early electrical remodeling: transcriptional downregulation of ion channel subunits reduces ICa,Land Itoin rapid atrial pacing in rabbits

BOSCH, R. F., Scherer, C. R., Rüb, N., Wöhrl, S., Steinmeyer, K., Haase, H., Busch, A. E., Seipel, L., & Kühlkamp, V. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02922-4 · Cited by 114 · see citing works

Tertiapin, a selective IKACh blocker, terminates atrial fibrillation with selective atrial effective refractory period prolongation

Hashimoto, N., YAMASHITA, T., & Tsuruzoe, N. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.03.021 · Cited by 114 · see citing works

Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation. Sotalol vs bisoprolol

Plewan, A. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2546 · Cited by 111 · see citing works

Prevention of atrial fibrillation by way of abrogation of the renin-angiotensin system: a systematic review and meta-analysis

Jibrini, M. B., Molnar, J., & Arora, R. R. (2008) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e31804beb59 · Cited by 111 · see citing works

Protective effects of SEA0400, a novel and selective inhibitor of the Na+/Ca2+ exchanger, on myocardial ischemia–reperfusion injuries

Takahashi, K., Takahashi, T., Suzuki, T., Onishi, M., Tanaka, Y., Hamano-Takahashi, A., Ota, T., Kameo, K., Matsuda, T., & Baba, A. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02732-2 · Cited by 109 · see citing works

Changes in IK,ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes

Voigt, N., Maguy, A., Yeh, Y., Qi, X., Ravens, U., Dobrev, D., & Nattel, S. (2007) · Cardiovascular Research · doi:10.1093/cvr/cvm051 · Cited by 109 · see citing works

Kv1.5 Is an Important Component of Repolarizing K + Current in Canine Atrial Myocytes

Fedida, D., Eldstrom, J., Hesketh, J. C., Lamorgese, M., Castel, L., Steele, D. F., & Wagoner, D. R. V. (2003) · Circulation Research · doi:10.1161/01.res.0000096362.60730.ae · Cited by 109 · see citing works

Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent

Fedida, D. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.4.519 · Cited by 108 · see citing works

AZD7009:

Goldstein, R. N., Khrestian, C. M., Carlsson, L. G., & Waldo, A. L. (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.04354.x · Cited by 108 · see citing works

Contrasting Efficacy of Dofetilide in Differing Experimental Models of Atrial Fibrillation

Li, D., Benardeau, A. M., & Nattel, S. (2000) · Circulation · doi:10.1161/01.cir.102.1.104 · Cited by 107 · see citing works

Distribution of the Muscarinic K + Channel Proteins Kir3.1 and Kir3.4 in the Ventricle, Atrium, and Sinoatrial Node of Heart

Dobrzynski, H., Marples, D. D. R., Musa, H., Yamanushi, T. T., Hendersonxyl, Z., Takagishi, Y., Honjo, H., Kodama, I., & Boyett, M. R. (2001) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540104901004 · Cited by 106 · see citing works

Ranolazine Exerts Potent Effects on Atrial Electrical Properties and Abbreviates Atrial Fibrillation Duration in the Intact Porcine Heart

Kumar, K., Nearing, B. D., Carvas, M., Nascimento, B., Acar, M., Belardinelli, L., & Verrier, R. L. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01437.x · Cited by 105 · see citing works

Chronic and Acute Effects of Dronedarone on the Action Potential of Rabbit Atrial Muscle Preparations: Comparison With Amiodarone

Sun, W., Sarma, J. S. M., & Singh, B. N. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200205000-00008 · Cited by 105 · see citing works

New 1,4‐benzothiazepine derivative, K201, demonstrates cardioprotective effects against sudden cardiac cell death and intracellular calcium blocking action

Kaneko, N. (1994) · Drug Development Research · doi:10.1002/ddr.430330406 · Cited by 102 · see citing works

Ranolazine: Ion‐channel‐blocking actions and <i>in vivo</i> electrophysiological effects

Schram, G., Zhang, L., Derakhchan, K., Ehrlich, J. R., Belardinelli, L., & Nattel, S. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705879 · Cited by 101 · see citing works

Effects of Amiodarone and Dronedarone on Voltage‐Dependent Sodium Current in Human Cardiomyocytes

Lalevée, N., Barrère‐Lemaire, S., Gautier, P., Nargeot, J., & Richard, S. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.03064.x · Cited by 99 · see citing works

Binding Site of a Novel Kv1.5 Blocker: A “Foot in the Door” against Atrial Fibrillation

Decher, N., Kumar, P., González, T., Pirard, B., & Sanguinetti, M. C. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026203 · Cited by 97 · see citing works

The Pathological Role of Transient Receptor Potential Channels in Heart Disease

Watanabe, H., Murakami, M., Ohba, T., Ono, K., & Ito, H. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1153 · Cited by 96 · see citing works

Na+/Ca2+ Exchange Inhibitors: A New Class of Calcium Regulators

Iwamoto, T., Watanabe, Y., Kita, S., & Blaustein, M. P. (2007) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/187152907781745288 · Cited by 95 · see citing works

Effect of 5-HT4 receptor stimulation on the pacemaker current If in human isolated atrial myocytes

Pino, R., Cerbai, E., Calamai, G., Alajmo, F., Borgioli, A., Braconi, L., Cassai, M., Montesi, G. F., & Mugelli, A. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00198-9 · Cited by 94 · see citing works

Pharmacology of amiodarone, and anti-anginal drug with a new biological profile.

Charlier, R., Deltour, G.-H., Baudine, A., & Chaillet, F. (1968) · PubMed · Cited by 94 · see citing works

New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value

Ford, J. W., & Milnes, J. T. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181719b0c · Cited by 93 · see citing works

Statins and polyunsaturated fatty acids for treatment of atrial fibrillation

Savelieva, I., & Camm, A. J. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1038 · Cited by 92 · see citing works

Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance

Savelieva, I., Kourliouros, A., & Camm, A. J. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0468-y · Cited by 92 · see citing works

Late Sodium Current is a Novel Target for Amiodarone: Studies in Failing Human Myocardium

Maltsev, V. A., Sabbah, H. N., & Undrovinas, A. I. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1355 · Cited by 92 · see citing works

Amiodarone and Torsade de Pointes

Lazzara, R. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-7-549 · Cited by 90 · see citing works

Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels

G�gelein, H., Brendel, J., Steinmeyer, K., Str�bing, C., Picard, N., Rampe, D., Kopp, K., Busch, A. E., & Bleich, M. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0957-y · Cited by 90 · see citing works

Cellular electrophysiology of atrial fibrillation

BOSCH, R. F. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00529-6 · Cited by 89 · see citing works

Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides

Dhein, S., Hagen, A., Jozwiak, J., Dietze, A., Garbade, J., Barten, M. J., Kostelka, M., & Mohr, F. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0473-1 · Cited by 87 · see citing works

Regulation of spontaneous opening of muscarinic K+ channels in rabbit atrium.

Kaibara, M., Nakajima, T., Irisawa, H., & Giles, W. R. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018445 · Cited by 84 · see citing works

Tedisamil inactivates transient outward K+ current in rat ventricular myocytes

Dukes, I. D., & Morad, M. (1989) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1989.257.5.h1746 · Cited by 82 · see citing works

Effects of antiarrhythmic drugs on cloned cardiac voltage-gated potassium channels expressed in Xenopus oocytes

Rolf, S., Haverkamp, W., Borggrefe, M., Mußhoff, U., Eckardt, L., Mergenthaler, J., Snyders, D. J., Pongs, O., Speckmann, E., Breithardt, G., et al. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000257 · Cited by 81 · see citing works

A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia

Dhein, S., Manicone, N., M�ller, A., Gerwin, R., Ziskoven, U., Irankhahi, A., Minke, C., & Klaus, W. (1994) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00241093 · Cited by 81 · see citing works

Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter

Hohnloser, S. H., Dorian, P., Straub, M., Beckmann, K., & Kowey, P. R. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.047 · Cited by 81 · see citing works

AVE0118, Blocker of the Transient Outward Current ( I to ) and Ultrarapid Delayed Rectifier Current ( I Kur ), Fully Restores Atrial Contractility After Cardioversion of Atrial Fibrillation in the Goat

de Haan, S., Greiser, M., Harks, E. G. A., Blaauw, Y., van Hunnik, A., Verheule, S., Allessie, M. A., & Schotten, U. (2006) · Circulation · doi:10.1161/circulationaha.106.630905 · Cited by 76 · see citing works

Do statins have an antiarrhythmic activity?

Kostapanos, M. S., Liberopoulos, E. N., Goudevenos, J. A., Mikhailidis, D. P., & Elisaf, M. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.02.029 · Cited by 75 · see citing works

Angiotensin II stimulates cardiac L-type Ca2+current by a Ca2+- and protein kinase C-dependent mechanism

Aiello, E. A., & Cingolani, H. E. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.4.h1528 · Cited by 74 · see citing works

Anticholinergic Effects of Class III Antiarrhythmic Drugs in Guinea Pig Atrial Cells

Mori, K., Hara, Y., Saito, T., Masuda, Y., & Nakaya, H. (1995) · Circulation · doi:10.1161/01.cir.91.11.2834 · Cited by 74 · see citing works

Pharmacological Characterization of the New Stable Antiarrhythmic Peptide Analog Ac-d-Tyr-d-Pro-d-Hyp-Gly-d-Ala-Gly-NH2 (ZP123): In Vivo and in Vitro Studies

Kjølbye, A. L., Knudsen, C., Jepsen, T., Larsen, B. D., & Petersen, J. S. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052258 · Cited by 74 · see citing works

The antiarrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin 43

Clarke, T. C., Thomas, D. G., Petersen, J. S., Evans, W. H., & Martin, P. E. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706631 · Cited by 74 · see citing works

Mechanism of Action of the Antiarrhythmic Agent AZD7009

Persson, F. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University) · doi:10.1046/j.1540-8167.2005.40427.x · Cited by 73 · see citing works

Effects of a Novel Cardioprotective Drug, JTV-519, on Membrane Currents of Guinea Pig Ventricular Myocytes

Junko, K., Masanori, K., Eiichi, S., Junichi, Y., & Hironori, N. (1999) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.79.275 · Cited by 73 · see citing works

Electrophysiological and antiarrhythmic effects of the novel I Kur channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I Kr blockers dofetilide, azimilide, d,l-sotalol and ibutilide

Knobloch, K., Brendel, J., Peukert, S., Rosenstein, B., Busch, A. E., & WIRTH, K. J. (2002) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-002-0599-x · Cited by 72 · see citing works

New Approaches to Atrial Fibrillation Management

Nattel, S., Khairy, P., Roy, D., Thibault, B., Guerra, P. G., Talajic, M. R., & Dubuc, M. (2002) · Drugs · doi:10.2165/00003495-200262160-00005 · Cited by 72 · see citing works

The efficacy of azimilide in the treatment of atrial fibrillation in the presence of left ventricular systolic dysfunction

Pratt, C. M., Singh, S. N., Al‐Khalidi, H. R., Brum, J. M., Holroyde, M. J., Marcello, S. R., Schwartz, P. J., & Camm, A. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.057 · Cited by 72 · see citing works

Inhibitory Effects of Dronedarone on Muscarinic K+ Current in Guinea Pig Atrial Cells

Guillemare, E., Marion, A., Nisato, D., & Gautier, P. (2000) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200012000-00017 · Cited by 71 · see citing works

Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the β‐adrenoceptor and adenylate cyclase in rat heart

Chatelain, P., Meysmans, L., Mattéazzi, J. R., Beaufort, P., & Clinet, M. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16397.x · Cited by 70 · see citing works

Regulation of two‐pore‐domain (K2P) potassium leak channels by the tyrosine kinase inhibitor genistein

Gierten, J., Ficker, E. K., Bloehs, R., Schlömer, K., Kathöfer, S., Scholz, E. P., Zitron, E., Kiesecker, C., Bauer, A., Becker, R., et al. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.213 · Cited by 70 · see citing works

Increase in gap junction conductance by an antiarrhythmic peptide

Müller, A. M. F., Gottwald, M., Tudyka, T., Linke, W., Klaus, W., & Dhein, S. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)89679-3 · Cited by 70 · see citing works

The Antiarrhythmic Peptide Analog ZP123 Prevents Atrial Conduction Slowing During Metabolic Stress

Haugan, K., Olsen, K. B., Hartvig, L., Petersen, J. S., Holstein‐Rathlou, N., Hennan, J. K., & Nielsen, M. S. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.40687.x · Cited by 70 · see citing works

[Autonomously promoted extension effect in Purkinje fibers, papillary muscles and trabeculae carneae of rhesus monkeys].

KAUFMANN, R. L., & Theophile, U. (1967) · PubMed · Cited by 69 · see citing works

Antiarrhythmic Effects of JTV‐519, a Novel Cardioprotective Drug, on Atrial Fibrillation/Flutter in a Canine Sterile Pericarditis Model

Kumagai, K., Nakashima, H., Gondo, N., & Saku, K. (2003) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2003.03050.x · Cited by 67 · see citing works

Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle

Jahnel, U., Rupp, J., Ertl, R., & Nawrath, H. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169000 · Cited by 67 · see citing works

Anti-Ischemic Effect of a Novel Cardioprotective Agent, JTV519, Is Mediated Through Specific Activation of δ-Isoform of Protein Kinase C in Rat Ventricular Myocardium

Inagaki, K., Kihara, Y., Hayashida, W., Izumi, T., Iwanaga, Y., Yoneda, T., Takeuchi, Y., Suyama, K., Muso, E., & Sasayama, S. (2000) · Circulation · doi:10.1161/01.cir.101.7.797 · Cited by 66 · see citing works

Electrophysiological and Antiarrhythmic Effects of the Atrial Selective 5-HT 4 Receptor Antagonist RS-100302 in Experimental Atrial Flutter and Fibrillation

Rahme, M. M., Cotter, B. R., Leistad, E., Wadhwa, M. K., Mohabir, R., Ford, A. P. D. W., Eglen, R. M., & Feld, G. K. (1999) · Circulation · doi:10.1161/01.cir.100.19.2010 · Cited by 66 · see citing works

Characterization of In Vivo and In Vitro Electrophysiological and Antiarrhythmic Effects of a Novel IKACh Blocker, NIP-151: A Comparison With an IKr-Blocker Dofetilide

Hashimoto, N., Yamashita, T., & Tsuruzoe, N. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31815e854c · Cited by 65 · see citing works

New developments in atrial antiarrhythmic drug therapy

Burashnikov, A., & Antzelevitch, C. N. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.245 · Cited by 64 · see citing works

Roles of TRP channels in the development of cardiac hypertrophy

Nishida, M., & Kurose, H. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-008-0321-8 · Cited by 64 · see citing works

Blockade of atrial-specific K+-currents increases atrial but not ventricular contractility by enhancing reverse mode Na+/Ca2+-exchange

Schotten, U., DEHAAN, S., Verheule, S., Harks, E. G. A., Frechen, D., Bodewig, E., Greiser, M., Ram, R., Maessen, J. G., & Kelm, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.11.024 · Cited by 64 · see citing works

Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009

Crijns, H. J. G. M., Gelder, I. C. V., Walfridsson, H., Kułakowski, P., Rónaszéki, A., Dedek, V., Malm, A. R., & Almgren, O. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.06.035 · Cited by 62 · see citing works

In Vivo Antiarrhythmic and Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide

Stump, G. L., Wallace, A. A., Regan, C. P., & Lynch, J. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.092197 · Cited by 61 · see citing works

New Insights Into the Initiation of Atrial Fibrillation

Hoffmann, E., Sulke, N., Edvardsson, N. G., Ruiter, J. H., Lewalter, T., Capucci, A., Schuchert, A., Janko, S., & Camm, A. J. (2006) · Circulation · doi:10.1161/circulationaha.105.568568 · Cited by 61 · see citing works

The role of stretch-activated channels in atrial fibrillation and the impact of intracellular acidosis

Ninio, D. M., & Saint, D. A. (2008) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2008.02.016 · Cited by 60 · see citing works

Characterization of a [Ca2+]i-dependent current in human atrial and ventricular cardiomyocytes in the absence of Na+ and K+

Köster, O. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00202-8 · Cited by 60 · see citing works

Is there a role for remodeled connexins in AF? No simple answers

Duffy, H. S., & Wit, A. L. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.016 · Cited by 60 · see citing works

Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans

Kjølbye, A. L., Dikshteyn, M., Eloff, B. C., Deschênes, I., & ROSENBAUM, D. S. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01089.2006 · Cited by 60 · see citing works

Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters.

AONUMA, S., Kohama, Y., Akai, K., Komiyama, Y., Nakajima, S., WAKABAYASHI, M., & MAKINO, T. (1980) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.28.3332 · Cited by 60 · see citing works

Atrial Structural Remodeling as an Antiarrhythmic Target

Burstein, B., & Nattel, S. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181668057 · Cited by 59 · see citing works

Drug therapy for atrial fibrillation: where do we go from here?

Page, R. L., & Roden, D. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1876 · Cited by 59 · see citing works

Inhibitory Profile of SEA0400 [2-[4-[(2,5-Difluorophenyl)methoxy]phenoxy]-5-ethoxyaniline] Assessed on the Cardiac Na+-Ca2+ Exchanger, NCX1.1

Lee, C. Y. W., Visen, N. S., Dhalla, N. S., Le, H. D., Isaac, M., Choptiany, P., Gross, G. J., Omelchenko, A., Matsuda, T., Baba, A., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070805 · Cited by 59 · see citing works

Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation

Voigt, N., Rozmaritsa, N., Trausch, A., Zimniak, T., Christ, T., Wettwer, E., Matschke, K., Dobrev, D., & Ravens, U. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0452-6 · Cited by 58 · see citing works

Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation

Antzelevitch, C. N., & Burashnikov, A. (2009) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2009.07.007 · Cited by 58 · see citing works

The human cardiac K2P3.1 (TASK-1) potassium leak channel is a molecular target for the class III antiarrhythmic drug amiodarone

Gierten, J., Ficker, E. K., Bloehs, R., Schweizer, P. A., Zitron, E., Scholz, E. P., Karle, C. A., Katus, H. A., & Thomas, D. (2009) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-009-0454-4 · Cited by 57 · see citing works

Na channels that remain open throughout the cardiac action potential plateau

Liu, Y. M., DeFelice, L. J., & Mazzanti, M. (1992) · Biophysical Journal · doi:10.1016/s0006-3495(92)81635-1 · Cited by 57 · see citing works

Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis

Ko, D., Rahman, F., Schnabel, R. B., Yin, X., Benjamin, E. J., & Christophersen, I. E. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.45 · Cited by 353 · see citing works

Small-conductance calcium-activated potassium (SK) channels contribute to action potential repolarization in human atria

Skibsbye, L., Poulet, C. E., Diness, J. G., Bentzen, B. H., Yuan, L., Kappert, U., Matschke, K., Wettwer, E., Ravens, U., Grunnet, M., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu121 · Cited by 198 · see citing works

The HARMONY Trial

Reiffel, J. A., Camm, A. J., Belardinelli, L., Zeng, D., Karwatowska‐Prokopczuk, E., Olmsted, A., Zaręba, W., Rosero, S. Z., & Kowey, P. R. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.002856 · Cited by 164 · see citing works

Ultra-rapid delayed rectifier channels: molecular basis and therapeutic implications

Ravens, U., & Wettwer, E. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq398 · Cited by 133 · see citing works

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management

Gillis, A. M., Verma, A., Talajic, M. R., Nattel, S., & Dorian, P. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.11.001 · Cited by 122 · see citing works

Atrial selectivity of antiarrhythmic drugs

Ravens, U., Poulet, C. E., Wettwer, E., & Knaut, M. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.256115 · Cited by 90 · see citing works

The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: A critical reassessment

Billman, G. E. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.05.011 · Cited by 69 · see citing works

The CURE-AF trial: A prospective, multicenter trial of irrigated radiofrequency ablation for the treatment of persistent atrial fibrillation during concomitant cardiac surgery

Damiano, R. J., Badhwar, V., Acker, M. A., Veeragandham, R. S., Kress, D. C., Robertson, J. O., & Sundt, T. M. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.10.004 · Cited by 61 · see citing works

Atrial fibrillation: Therapeutic potential of atrial K + channel blockers

Ravens, U., & Odening, K. E. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.10.003 · Cited by 61 · see citing works

Effects of IKur blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation

Loose, S., Mueller, J., Wettwer, E., Knaut, M., Ford, J., Milnes, J., & Ravens, U. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00026 · Cited by 49 · see citing works

Mechanisms of termination and prevention of atrial fibrillation by drug therapy

Workman, A. J., Smith, G. L., & RANKIN, A. C. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.02.002 · Cited by 44 · see citing works

Ionic basis of cardiac electrophysiology in zebrafish compared to human hearts

Ravens, U. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.06.008 · Cited by 43 · see citing works

Atria-selective antiarrhythmic drugs in need of alliance partners

Peyronnet, R., & Ravens, U. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104262 · Cited by 40 · see citing works

Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans

Walfridsson, H., Anfinsen, O.-G., Berggren, A., Frison, L., Jensen, S. M., Linhardt, G., Nordkam, A.-K., Sundqvist, M., & Carlsson, L. G. (2014) · EP Europace · doi:10.1093/europace/euu192 · Cited by 39 · see citing works

Atrial Fibrillation Dynamics and Ionic Block Effects in Six Heterogeneous Human 3D Virtual Atria with Distinct Repolarization Dynamics

Sánchez, C., Bueno‐Orovio, A., Pueyo, E., & Rodríguez, B. (2017) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2017.00029 · Cited by 37 · see citing works

Effect of selective IK,ACh inhibition by XAF‐1407 in an equine model of tachypacing‐induced persistent atrial fibrillation

Fenner, M. F., Carstensen, H., Nissen, S. D., Hesselkilde, E. M., Lunddahl, C. S., Jensen, M. A. H., Loft‐Andersen, A. V., Sattler, S. M., Platonov, P. G., El-Haou, S., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15100 · Cited by 33 · see citing works

New drugs vs. old concepts: A fresh look at antiarrhythmics

Thireau, J., Pasquié, J., Martel, E., Guennec, J. L., & Richard, S. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.03.003 · Cited by 32 · see citing works

Atrial-selective K+ channel blockers: potential antiarrhythmic drugs in atrial fibrillation?

Ravens, U. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0024 · Cited by 30 · see citing works

Novel pharmacological targets for the rhythm control management of atrial fibrillation

Burashnikov, A., & Antzelevitch, C. N. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.08.002 · Cited by 29 · see citing works

Advances in basic and translational research in atrial fibrillation

Hu, D., Barajas-Martínez, H., Zhang, Z., Duan, H.-Y., Zhao, Q., Bao, M., Du, Y., Burashnikov, A., Monasky, M. M., Pappone, C., et al. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0174 · Cited by 27 · see citing works

Adenosine A2A Receptors Are Upregulated in Peripheral Blood Mononuclear Cells from Atrial Fibrillation Patients

Godoy-Marín, H., Duroux, R., Jacobson, K. A., Soler, C., Colino-Lage, H., Jiménez-Sábado, V., Montiel, J., Hove‐Madsen, L., & Ciruela, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073467 · Cited by 19 · see citing works

Transient receptor potential: a large family of new channels of which several are involved in cardiac arrhythmiaThis article is one of a selection of papers from the NATO Advanced Research Workshop on Translational Knowledge for Heart Health (published in part 1 of a 2-part Special Issue).

Vassort, G., & Álvarez, J. L. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-112 · Cited by 18 · see citing works

Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation

Borrego, J., Fehér, Á. M., Jost, N., Panyi, G., Varga, Z., & Papp, F. (2021) · Pharmaceuticals · doi:10.3390/ph14121303 · Cited by 17 · see citing works

Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies

Grigoriou, K., Karakasis, P., Pamporis, K., Theofilis, P., Patoulias, D., Karagiannidis, E., Fyntanidou, B., Antoniadis, A. P., & Fragakis, N. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070559 · Cited by 14 · see citing works

A Novel Insecticidal Spider Peptide that Affects the Mammalian Voltage-Gated Ion Channel hKv1.5

Alvarado, D., Cardoso-Arenas, S., Corrales-García, L. L., Clement, H. C., Arenas, I., Montero-Dominguez, P. A., Olamendi‐Portugal, T., Zamudio, F. Z., Csóti, A., Borrego, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.563858 · Cited by 14 · see citing works

Neurokinin-3 receptor activation selectively prolongs atrial refractoriness by inhibition of a background K+ channel

Veldkamp, M. W., Geuzebroek, G. S. C., Baartscheer, A., Verkerk, A. O., Schumacher, C. A., Suarez, G. G., Berger, W. R., Casini, S., van Amersfoorth, S. C. M., Scholman, K. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06530-5 · Cited by 12 · see citing works

New Strategies for the Treatment of Atrial Fibrillation

Jost, N., Christ, T., & Magyar, J. (2021) · Pharmaceuticals · doi:10.3390/ph14090926 · Cited by 11 · see citing works

Atrial Remodeling in Permanent Atrial Fibrillation: Mechanisms and Pharmacological Implications

Muntean, D. M., Kohajda, Z., Fazekas, T., & Jost, N. (2013) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000273 · Cited by 8 · see citing works

Sinus Rhythm Maintenance After Electrical Cardioversion for Atrial Fibrillation in High-Risk Patients — Comparative Efficacy of Antiarrhythmic Medications

Kokina, B., Strēlnieks, A., Pupkeviča, I., Jubele, K., Vikmane, M., Sakne, S., Sokolova, E., Urtāne, I., Lejnieks, A., & Kalējs, O. (2021) · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences · doi:10.2478/prolas-2021-0006 · Cited by 7 · see citing works

54 – Pharmacologic Bases of Antiarrhythmic Therapy

Tamargo, J., & Delpón, E. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00054-6 · Cited by 4 · see citing works

Rational design, synthesis, and evaluation of novel polypharmacological compounds targeting NaV1.5, KV1.5, and K2P channels for atrial fibrillation

Camargo-Ayala, L., Bedoya, M., Dasí, A., Prüser, M., Schütte, S., Prent-Peñaloza, L., Adasme‐Carreño, F., Kiper, A. K., Rinné, S., Camargo-Ayala, P. A., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108387 · Cited by 6 · see citing works

54 – Pharmacological Bases of Antiarrhythmic Therapy

Tamargo, J., & Delpón, E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-44733-1.00054-7 · Cited by 1 · see citing works

Electrophysiological Characterization and Antiarrhythmic Efficacy of the Mixed Potassium Channel-Blocking Antiarrhythmic Agent AZ13395438 In Vitro and In Vivo

Jacobson, I., Duker, G., Florentzson, M., Linhardt, G., Lindhardt, E., Nordkam, A.-K., Åstrand, A., & Carlsson, L. G. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248412470512 · Cited by 4 · see citing works

Antiarrhythmic principle of SK channel inhibition in atrial fibrillation.

Skibsbye, L. (2015) · PubMed · Cited by 3 · see citing works

The Pathophysiological Implications of TRP Channels in Cardiac Arrhythmia

Inoue, R., Duan, Y., Yaopeng, H., & Ichikaw, J. (2012) · InTech eBooks · doi:10.5772/32249 · Cited by 2 · see citing works

Mathematical Modelling of Leptin-Induced Effects on Electrophysiological Properties of Rat Cardiomyocytes and Cardiac Arrhythmias

Nesterova, T., Rokeakh, R., Solovyova, O. E., & Panfilov, A. V. (2023) · Mathematics · doi:10.3390/math11040874 · Cited by 1 · see citing works

Advanced Molecular Modeling Techniques Applied to Ion Channels Blockers

Hannongbua, S., Treesuwan, W., & Boonyarat, W. (2011) · Springer eBooks · doi:10.1007/978-3-642-19922-6_3 · Cited by 1 · see citing works

Society Guidelines Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Rate and Rhythm Management

Gillis, A. M., Verma, A., Talajic, M. R., Nattel, S., & Dorian, P. (2011) · Cited by 1 · see citing works

Polypharmacological Modulation of Atrial Fibrillation: Rational Design, Synthesis, and Evaluation of Novel Compounds Targeting NaV1.5, KV1.5, and K2P ChannelsPreprint

Camargo-Ayala, L., Bedoya, M., Dasí, A., Prüser, M., Prent-Peñaloza, L., Adasme‐Carreño, F., Kiper, A. K., Rinné, S., Camargo-Ayala, P. A., Peña-Martínez, P. A., et al. (2024) · ChemRxiv · doi:10.26434/chemrxiv-2024-v70lj · Cited by 1 · see citing works

Neue Entwicklungen in der antiarrhythmischen Therapie des Vorhofflimmerns

Ravens, U. (2014) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-014-0302-1

Effektivität und Sicherheit der Katheterablation bei Vorhof- flimmern: Ergebnisse des prospektiven, multizentrischen Vorhofflimmerablationsregisters

Willems, S. (2012)

Modulation of cardiac Kv currents by Kvbeta2 and pyridine nucleotides.

Kilfoil, P. J. (2016) · doi:10.18297/etd/2400

COMPARATIVE ANALYSIS OF THE RISK FACTORS FOR EMBOLIC STROKE DEVELOPMENT

Vorozhtsova, I. N., Vasiltseva, O. Y., & Gorlova, A. A. (2018) · Siberian medical review · doi:10.20333/2500136-2018-1-49-53

Destruction Of Medium Already Afected By Destructive Disorder: Fibrillating Atria Conceptually Need Therapeutic Help Rather Than Surgical Or Ablative Destruction.

Stirbys, P. (2014) · PubMed Central · doi:10.4022/jafib.1082

Effects of SZV-2649, a new multiple ion channel inhibitor mexiletine analogue

Mohammed, A. S. A., Naveed, M., Szabados, T., Szatmári, I., Lőrinczi, B., Mátyus, P., Czompa, A., Orvos, P., Husti, Z., Hornyik, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-73576-5

Catheter Ablation vs Antiarrhythmic Agents in Patients with Atrial Fibrillation: A Systematic Review and Meta-AnalysisPreprint

Barboza, J. J., Paz, F. D., Saldaña, C. D., Ayca, M. S., Alarcón, M. J., Medrano, J. M., Luque, A. H., Bonilla-Asalde, C., & Rivera-Lozada, O. (2025) · Research Square · doi:10.21203/rs.3.rs-7820043/v1

Effect of catheter ablation and pharmacotherapy on long‐term mortality in young patients with atrial fibrillation

D’Elia, N. W., Dragas, M., Bevacqua, F., Prabhu, S., Sugumar, H., Chieng, D., Segan, L. A., Ling, L. H., Cho, K., William, J., et al. (2026) · Internal Medicine Journal · doi:10.1111/imj.70549

Novel pharmacological approaches for antiarrhythmic therapy

Ravens, U. (2010) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0487-8 · Cited by 27 · see citing works

Ion Channels as New Drug Targets in Atrial Fibrillation

Ravens, U. (2011) · Springer eBooks · doi:10.1007/978-3-642-17575-6_33

Ion Channels as Drug Targets in Atrial Fibrillation

Ravens, U., & Peyronnet, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-33588-4_28

Recent Advances in Antiarrhythmic Drug Treatment of Atrial Fibrillation

Polovina, M. M., & Potpara, T. (2013) · Recent Advances in Cardiovascular Drug Discovery (Formerly Recent Patents on Cardiovascular Drug Discovery) · doi:10.2174/15748901113089990016 · Cited by 5 · see citing works

Emerging Antiarrhythmic Drugs for Atrial Fibrillation

Saljic, A., Heijman, J., & Dobrev, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084096 · Cited by 60 · see citing works